Description
Qualitative and quantitative compostion:
Each tablet contains 25 mg tetrabenazine.
Excipient: Each tablet also contains 64 mg of lactose monohydrate.
Therapeutic indications:
Movement disorders associated with organic central nervous system conditions, e.g., Huntington's chorea, hemiballismus and senile chorea.
Xenazine 25 is also indicated for the treatment of moderate to severe tardive dyskinesia.
Signup to K2
Register today for a Kays Medical trade account and begin using K2 to place orders securely and conveniently for immediate delivery.
Click here to signup or if already registered click here to login.